Amalgamated Bank Grows Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Amalgamated Bank boosted its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 8.4% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 5,330 shares of the company’s stock after buying an additional 412 shares during the period. Amalgamated Bank’s holdings in Addus HomeCare were worth $619,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. UMB Bank n.a. grew its position in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after purchasing an additional 88 shares in the last quarter. Quest Partners LLC purchased a new position in Addus HomeCare in the 2nd quarter worth approximately $31,000. EntryPoint Capital LLC bought a new position in Addus HomeCare in the 1st quarter worth approximately $44,000. Innealta Capital LLC purchased a new stake in Addus HomeCare during the 2nd quarter valued at approximately $44,000. Finally, GAMMA Investing LLC raised its position in shares of Addus HomeCare by 40.8% during the first quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after buying an additional 161 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the transaction, the director now directly owns 3,866 shares in the company, valued at $502,695.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 22,917 shares of company stock worth $3,050,082. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Down 0.7 %

Shares of Addus HomeCare stock opened at $130.95 on Friday. Addus HomeCare Co. has a 52 week low of $78.35 and a 52 week high of $136.12. The company has a market capitalization of $2.37 billion, a PE ratio of 32.49, a price-to-earnings-growth ratio of 2.40 and a beta of 1.04. The stock’s fifty day moving average is $128.25 and its two-hundred day moving average is $115.31.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. During the same period last year, the company posted $0.94 earnings per share. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. As a group, research analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on ADUS shares. StockNews.com downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. Stephens reaffirmed an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research note on Tuesday, August 6th. TD Cowen upped their price objective on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Royal Bank of Canada reissued an “outperform” rating and issued a $141.00 target price on shares of Addus HomeCare in a report on Tuesday, September 3rd. Finally, Oppenheimer boosted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating and eight have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $128.29.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.